Analysis of early viral kinetics in chronic hepatitis C genotype 2 or 3 patients treated with peginterferon Alpha-2a and ribavirin

被引：0
|
作者：
Scherzer, Thomas-Matthias
Staufer, Katharina
Steindl-Munda, Petra
Holzmann, Heidemarie
Ferenci, Peter
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A789 / A789
页数：1
相关论文
共 50 条
  • [1] Early viral kinetics in patients with chronic hepatitis C genotype 2 or 3 treated with peginterferon α-2a and ribavirin
    Scherzer, Th-M.
    Staufer, K.
    Steindl-Munda, P.
    Holzmann, H.
    Ferenci, P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S244 - S244
  • [2] Treatment of Chronic Hepatitis C Genotype 4 with Peginterferon alpha-2a plus Ribavirin
    Varghese, R.
    Al-Khaldi, J.
    Asker, H.
    Fadili, A. A.
    Al-Ali, J.
    Hesasn, F. A.
    HEPATO-GASTROENTEROLOGY, 2009, 56 (89) : 218 - 222
  • [3] Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin
    Harrison, Stephen A.
    Hamzeh, Fayez M.
    Han, Jian
    Pandya, Prashant K.
    Sheikh, Muhammed Y.
    Vierling, John M.
    HEPATOLOGY, 2012, 56 (02) : 464 - 473
  • [4] Early predictors of sustained viral response (SVR) in chronic hepatitis C (Genotype 4) patients treated with pegylated interferon alpha-2a and ribavirin
    Elmakhzangy, HI
    Rekacewicz, C
    Shouman, S
    Mohamed, HN
    Esmat, G
    Mansour, AA
    Ismail, A
    Rafaat, R
    Elhosseiny, M
    Eldaly, M
    Elkafrawy, S
    Abdel-Hamid, M
    Fontanet, A
    Pol, S
    Mohamed, MK
    GASTROENTEROLOGY, 2005, 128 (04) : A714 - A714
  • [5] Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C
    Di Bisceglie, A. M.
    Ghalib, R. H.
    Hamzeh, F. M.
    Rustgi, V. K.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 721 - 729
  • [6] Peginterferon alpha-2a (40kD) monotherapy vs peginterferon alpha-2a and ribavirin in naive patients with chronic hepatitis C: Preliminary results of the SMIEC II trial in patients with early viral clearance on peginterferon monotherapy
    Piccolo, P
    Horst, BK
    Angelico, F
    Gentile, S
    Francioso, S
    Tarquini, P
    Della Vecchia, R
    Ponti, L
    Barlattani, A
    Grieco, A
    Soccorsi, F
    Guarascio, P
    Demelia, L
    Sorbello, O
    Forlini, G
    Bandiera, F
    Zaru, S
    Angelico, M
    JOURNAL OF HEPATOLOGY, 2004, 40 : 148 - 148
  • [7] ADVERSE REACTIONS TO THE COMBINED THERAPY OF PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C
    Faus Soler, Ma Teresa
    Zaragoza Marcet, Angela
    Escobar Cava, Paloma
    Tenias Burillo, Jost Ma
    Sangrador Garcia, Guillermo
    ATENCION FARMACEUTICA, 2009, 11 (02): : 110 - 116
  • [8] Impact of sex on virologic response rates in genotype 1 chronic hepatitis C patients with peginterferon alpha-2a and ribavirin treatment
    Yu, Jian-Wu
    Sun, Li-Jie
    Zhao, Yong-Hua
    Kang, Peng
    Yan, Bing-Zhu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (11) : E740 - E746
  • [9] STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 3 DOESN'T AFFECT THE OUTCOME OF PEGINTERFERON ALPHA-2a PLUS RIBAVIRIN TREATMENT
    Preveden, T. A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S494 - S494
  • [10] Peginterferon alpha-2a and ribavirin combination therapy for chronic hepatitis C in patients with hemophilia - preliminary report
    Kim, H.
    Yoo, K.
    Lee, K.
    Lee, Y.
    HAEMOPHILIA, 2008, 14 : 41 - 41
12345